Hepatocellular Carcinoma Drugs (PD-1/PD-L1 Inhibitors, Tyrosine Kinase Inhibitors) Industry Report 2024: A $1.62 Billion Market Opportunity by 2028
January 24, 2024 13:42 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Hepatocellular Carcinoma Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global hepatocellular...
World Hepatocellular Carcinoma Treatment Market Analysis Report 2022-2027: Increasing Adoption for Biological Therapies & Anticipated Launch of Emerging Drugs Bodes Well for the Market
January 24, 2023 09:18 ET
|
Research and Markets
Dublin, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The "Hepatocellular Carcinoma Treatment Market Forecast- Epidemiology & Pipeline Analysis 2022-2027" report has been added to ResearchAndMarkets.com's...
Global Hepatocellular Carcinoma Treatment Market 2021-2025: Market Sizing, Market Forecast and Key Vendor Profiles
March 08, 2021 07:33 ET
|
Research and Markets
Dublin, March 08, 2021 (GLOBE NEWSWIRE) -- The "Global Hepatocellular Carcinoma Treatment Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The hepatocellular carcinoma...